The prevalence of HER2-positive breast cancer in Western population was approximately 15% to 20% of primary breast cancers [6], which was not much different compared to the estimated HER2 positivity rate in Asian population which was about 23.5% [7]. Here, ERBB2 is linked to breast carcinoma.